Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Teva
Farmers Insurance
Covington
Colorcon
Fuji

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,828,399

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,828,399
Title:TC-PTP inhibitors as APC activators for immunotherapy
Abstract: The invention encompasses the novel class of compounds represented by the Formula (I) below, which are inhibitors of the TC-PTP enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing TC-PTP mediated diseases, including cancer, via their use in the activation of antigen-presenting cells, like dendritic cells, for applications in the immunotherapeutic treatment of diseases. ##STR00001##
Inventor(s): Tremblay; Michel L. (Montreal, CA), Penafuerte; Claudia (Montreal, CA), Feldhammer; Matthew (Montreal, CA), Zogopoulos; George (Montreal, CA), Black; Cameron (Baie d\'Urfe, CA), Kennedy; Brian (Kirkland, CA)
Assignee: The Royal Institution For The Advancement Of Learning/McGill University (Montreal, CA)
Application Number:15/122,031
Patent Claims:see list of patent claims

Details for Patent 9,828,399

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up The Royal Institution For The Advancement Of Learning/McGill University (Montreal, CA) 2034-02-28 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Accenture
Chubb
Express Scripts
Chinese Patent Office
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.